Chapter 11 — Further Reading

Real sources only. Where I'm unsure of exact details, I describe the source rather than inventing a citation.

The central paper

Reynolds, Mann, and colleagues, "Carbohydrate quality and human health: a series of systematic reviews and meta-analyses," The Lancet, 2019.

This is the paper the chapter's §11.4 is built on, and it's worth reading properly rather than in summary. Note three things: the dose-response figures (the most persuasive part, and the part summaries omit), the fact that it pooled both observational and trial data and reports them separately, and the authors' own discussion of the limitations — which is more candid than most coverage of it was. For: everyone. This is the strongest single piece of evidence in Part II.

The WHO guidance on carbohydrate intake (who.int) draws on this and related work, and states its certainty ratings explicitly. Reading a guideline that grades its own confidence is a useful contrast with the diet books in Chapter 10.

The reference documents

Dietary Reference Intakes (National Academies) — the source for 14 g per 1,000 kcal and the 25/38 g figures. Free through the National Academies Press. Worth reading the committee's reasoning for why fiber gets an Adequate Intake rather than an RDA, which tells you something about the state of the evidence at the time it was set.

USDA FoodData Central — fdc.nal.usda.gov. Every figure in §11.6's table. Look up your own staples; the results are frequently surprising in both directions.

FDA guidance on dietary fiber (fda.gov) — including the definition of what counts as dietary fiber on a label and which isolated and synthetic fibers have been accepted. This is directly relevant to Case Study 2's chicory root fibre problem, and it's a genuinely interesting regulatory question: what makes an added compound "fiber"? For: anyone who wants to know why the number on the panel doesn't distinguish lentils from inulin.

The FDA-authorized health claims for oat beta-glucan and psyllium and blood cholesterol. Read the exact permitted wording — the hedging is instructive, and Chapter 30 explains why authorized health claims are worded the way they are.

On mechanisms

On bile acid sequestration and cholesterol: search for reviews on "viscous fiber LDL cholesterol mechanism" and, for the pharmaceutical parallel, on bile acid sequestrants (colestyramine, colesevelam). Seeing that a food component and a drug class share a mechanism is one of the more satisfying things in nutrition.

On short-chain fatty acids and colonocytes: search for reviews on butyrate and colonic epithelium. This is genuinely good biology and it's the mechanistic bridge to Chapter 27.

On energy density and satiety: the research of Barbara Rolls and colleagues at Penn State on energy density and food intake. The finding that people eat a fairly consistent mass of food is the mechanism underneath most of fiber's satiety effect, and Rolls has spent a career establishing it carefully. For: anyone who found the §11.3 energy-density box the most useful thing in the chapter — which many readers do.

On psyllium specifically

Search PubMed for "psyllium randomized" plus your outcome of interest — LDL, glycemic control, constipation, IBS. The evidence is unusually good for a supplement, and the fact that it works for both constipation and diarrhea is a genuinely interesting property that follows directly from §11.2's viscous-but-not-very-fermentable profile. For: anyone considering a fiber supplement. This is the one worth considering.

On fiber and IBS

The Monash University FODMAP resources (monashfodmap.com) — Monash developed the low-FODMAP approach and maintains the food composition data behind it. Note their own emphasis that it is a temporary, three-phase, dietitian-supervised protocol with structured reintroduction, not a permanent diet. That emphasis is frequently lost in popular use, and losing it causes real harm.

Guidelines from national gastroenterology bodies on fiber in IBS — the British Society of Gastroenterology and American College of Gastroenterology both publish guidance, and both distinguish fiber types rather than treating fiber as one thing. For: anyone with IBS, and any clinician who has ever said "eat more fiber" to someone with it.

Full treatment in Chapter 28.

On the supplement-versus-food question

Search for reviews comparing isolated versus intrinsic fiber and for discussion of why fiber supplement trials haven't reproduced the hard-outcome benefits of high-fiber diets. This is an unresolved and genuinely interesting question — food matrix, displacement, confounding, or all three — and it's the honest weak point in this chapter's argument. For: anyone who wants to know where this chapter is least certain.

Practical

Any decent legume cookbook, and I mean this seriously. The single biggest barrier to the chapter's recommendation is not belief but repertoire — most people in industrialized countries can cook two things with beans, and both are chilli. Search for regional cuisines where legumes are central: Indian dals, Middle Eastern and North African pulse dishes, Mexican bean preparations, Italian soups, Ethiopian misir wot. Every one of those traditions solved this problem centuries ago, and the recipes are better than anything a nutrition book will hand you.

And a genuinely useful free resource: most national health services publish plain-language fiber guides with food lists — the NHS (nhs.uk) and the USDA's MyPlate (myplate.gov) both have them, both are free, and both are unglamorous and accurate.

A note on what to be careful with

The failure mode here is unusual — this is a chapter arguing for something rather than against it, and the risk is that enthusiasm outruns the evidence.

So hold two things: the fiber evidence is about as good as nutrition evidence gets, and it is observational at its core, healthy-user bias fully applies, high-fiber diets differ from low-fiber diets in a dozen other ways, and the supplement trials haven't reproduced the outcomes. If those facts don't reduce your confidence at all, you're reading me the way this book tells you not to read anyone.

The practical recommendation survives that scrutiny — because it costs almost nothing, has a wide safety margin, and delivers benefits you'll notice regardless of whether the mortality curves are causal. That's a different and more honest argument than "the evidence proves it," and it's the one I'd rather you carried.